We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Molecular Profiles, XenoGesis Collaborate

News   Aug 04, 2014

 
Molecular Profiles, XenoGesis Collaborate
 
 
Advertisement
 

RELATED ARTICLES

Ultrapotent Compound Could Help Combat C. difficile

News

Scientists from Purdue University have advanced novel compounds that they have designed to help treat patients with Clostridioides difficile.

READ MORE

Study Investigates Racial Disparities in Clinical Trial Recruitment

News

Scientists are increasingly turning to electronic-based recruitment methods to encourage participation in clinical trials. Little is known about how this use of technology compares to more traditional clinical trial recruitment strategies, and some researchers worry that an overreliance on technology has the potential to exclude an eligible and interested diverse participant population.

READ MORE

CD19 in Brain Cells May Be Cause of Immunotherapy-Related Neurotoxicity

News

New research has uncovered the presence of CD19 -- a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple myeloma -- in brain cells that protect the blood brain barrier (BBB).

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE